"Epilepsy drugs may require strictest warning" by Bloomberg News | July 8, 2008
WASHINGTON - Makers of epilepsy medicines, led by Johnson & Johnson and GlaxoSmithKline PLC, may be required to add the Food and Drug Administration's strictest warning about an increased risk of suicidal thoughts and behavior to their products.
Sales of epilepsy drugs, often used to treat psychiatric disorders, topped $10.2 billion in the United States last year.
"There seems to be no compelling reason to ignore what appears to be a very clear empirical finding of an increase in suicidality, despite no obvious explanation for this finding," said Russell Katz, director of the FDA's Division of Neurology Products, in the documents.
About 101.8 million prescriptions were dispensed last year.
--MORE--"Ah, there is $$$$ to be made, so WHO CARES about a few "suicides," huh?
If you ask me, this is MURDER!!!!
One wonders, HOW have human beings survived for SO LONG without the magic of Big Pharma, huh?
